The present disclosure relates to a medicament for the treatment of disorders. In particular, but not exclusively, the invention relates to medicaments for restoring or improving neural transmission in damaged nerve cells. Certain aspects of the disclosure relate to medicaments for treatment of non-demyelinating neural disorders. Other aspects of the disclosure relate to medicaments for the treatment of demyelinating disorders.
